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Background {#sec005}
==========

Causes of morbidity and mortality are relevant parameters for documentation of the geographical burden of disease and for public health planning, involving programmatic needs, assessing intervention programmes, and reevaluation of health policies \[[@pone.0237313.ref001]\]. They are also relevant tools for keeping track of the health of populations as well as for effective response to changing epidemiological trends \[[@pone.0237313.ref002]--[@pone.0237313.ref004]\]. More so, they serve as tool for quality control of health care system. For instance, deaths that occur due to causes that should otherwise not be fatal at the instance of effective medical practice, known as amenable mortality is an indicator of national levels of personal health-care access and quality \[[@pone.0237313.ref002],[@pone.0237313.ref005]\].

Globally, there were 56.9 million deaths in 2016 from varying causes among different regions \[[@pone.0237313.ref006]\]. Ischemic heart disease and stroke are the global leading causes of death, accounting for a combined 15.2 million deaths in 2016 and have remained the leading causes of death globally in the prior 15 years \[[@pone.0237313.ref006]\]. The global burden of disease study 2017 reported ischemic heart disease, neonatal disorders and stroke as leading causes of early death \[[@pone.0237313.ref007]\]. Greater proportion of developing countries have mortality pattern that show larger proportion of infectious disease and the risk of death during pregnancy and childbirth whereas cardiovascular diseases, chronic respiratory diseases and cancers account for most deaths in the developed world \[[@pone.0237313.ref008]\]. Population-based data on pattern of morbidity and mortality are often lacking in developing countries, hospital based pattern of morbidity and mortality often offer best alternative \[[@pone.0237313.ref004]\].

Most mortality reviews in Nigeria emanated from the south-west \[[@pone.0237313.ref009]--[@pone.0237313.ref013]\], north \[[@pone.0237313.ref014],[@pone.0237313.ref015]\] and south east \[[@pone.0237313.ref016]\]. There is a paucity of data on morbidity and mortality pattern in the southern region. Hence, this study is aimed at bridging this gap by reviewing comprehensive data on morbidity and mortality in a tertiary institution in southern Nigeria.

Methods {#sec006}
=======

Study design {#sec007}
------------

This study took a retrospective descriptive cross-sectional method in analyzing causes of morbidity and mortality in University of Calabar Teaching Hospital (UCTH) from January 2012 to December, 2017.

Study area {#sec008}
----------

This study was conducted at University of Calabar Teaching Hospital, Calabar Cross River State, Nigeria, which is a 410 bed space capacity tertiary health care institution. The hospital is made up of 15 wards and 11 clinics. It is generally stratified into health care service department and administrative department, mortuary services and laundry and tailoring unit. The health care services is composed of laboratory department, nursing services, surgery, internal medicine, family medicine, pediatrics, obstetrics and gynecology, ophthalmology, physiotherapy, food and nutrition, orthopedics, accident and emergency, dental department, dialysis and blood bank units \[[@pone.0237313.ref017],[@pone.0237313.ref018]\]. Though there is no published annual admission and mortality data, there are more than 2000 deliveries annually in the centre \[[@pone.0237313.ref019]\]. Cross River State is one of the states that form the southern part of Nigeria with an area of 21,787km^2^ and a population of 2,892,988 (using the 2006 census) \[[@pone.0237313.ref020],[@pone.0237313.ref021]\]. The hospital is sited in Calabar metropolis which is a fusion of Calabar Municipality and Calabar South Local Government Areas ([Fig 1](#pone.0237313.g001){ref-type="fig"}) \[[@pone.0237313.ref022]\]

![Map of the studied area.](pone.0237313.g001){#pone.0237313.g001}

Study population {#sec009}
----------------

Patients who were admitted or died (while in admission) within 2012 and 2017 were included in the study. More so, it is pertinent to note that female subjects admitted for labour and delivery were part of the study population. Patients brought in dead before arrival were excluded.

Data collection {#sec010}
---------------

Data on demographics, causes of mortality and morbidity were retrospectively extracted from the health records department of the University of Calabar Teaching Hospital where they are coded based on international classification of disease-- 10 (ICD---10) \[[@pone.0237313.ref023]\]. The various ICD classifications were allotted by the staff of health record department. The data are usually updated daily via outgone and returning patient case notes (folder) and are compiled into quarterly report submitted to Medical Advisory Committee. The data entry into spreadsheet from the original report book was performed with the assistance of 6 trained research assistants.

Ethics approval {#sec011}
---------------

This study was approved by Health Research Ethical Committee (HREC) of the University of Calabar Teaching Hospital.

Statistical analysis {#sec012}
--------------------

Data generated in this study were entered and analyzed using SPSS version 22 (IBM Corps, Armonk, NY, USA). Frequencies and Percentages were used to represent the categorical variables. Pearson Chi square test was used to assess association between variables. Mantel Haenzel test of trend was used to assess linear association. Odd ratio was used to assess odd of occurrence in categorical variables. Alpha value was set at 0.05.

Results {#sec013}
=======

A total of 49,287 patients were admitted into the wards and accident and emergency (casualty ward) during the period of study. Of these, 2,198 died giving a mortality rate of 4.5%. Gender stratification showed that 1,152 (7.4%) out of 15,622 males admitted died while 1,046 (3.1%) of the 33,665 of the females admitted died. Mortality was significantly higher in male gender than their female counterparts with odd ratio of 2.483 (2.278--2.704). Further stratification of the admitted patients based on route of admission showed that 37.0% of the patients were admitted via casualty (accident and emergency) while 63.0% were admitted via wards. A greater proportion of the males (59.8%) were admitted via casualty while the reverse was the case for the female patients (as they were admitted more via the ward; family medicine). The disparity was statistical significant (P\< 0.05) ([Table 1](#pone.0237313.t001){ref-type="table"}).

10.1371/journal.pone.0237313.t001

###### Frequency of morbidity and mortality of the studied population based on gender.
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  Gender   N. admitted (%)   Deaths (%)                      M. rate (%)   X^2^      OR      P-value   CI
  -------- ----------------- ------------------------------- ------------- --------- ------- --------- --------------
  Male     15,622 (31.7)     1,152 (52.4)                    7.4           456.008   2.483   \<0.01    2.278--2.704
  Female   33,665 (68.3)     1,046 (47.6)                    3.1                     1                 
  Total    49,287 (100.0)    2,198 (100.0)                   4.5                                       
           Admission route                                                                             
           Via ward (%)      Via casualty (%) (jjjjj(% % %                 5108.04           \<0.01    
  Male     6,280 (40.2)      9,342 (59.8)                                                              
  Female   24,778 (73.6)     8,887 (26.4)                                                              
  Total    31,058 (63.0)     18,229 (37.0)                                                             

N.: absolute number

M.: mortality

[Table 2](#pone.0237313.t002){ref-type="table"} shows the distribution of frequency of morbidity and mortality of the patients within the study period based on age. Age range 15--45 years had the highest number (57.9%) of admissions followed by 1--4 years (11.7%) and \< 1 year (11.3%) age range. On the other hand, age range 15--45 years recorded the highest number (37.7%) of deaths followed by the 46--64 (23.8%) and the \> 65 years (16.1%) category. However, the age range \> 65 years recorded the highest number of deaths per admission giving rise to 16.5% mortality rate. The mortality rate increased as the age increased. The linear association was found to be significant (p\<0.05) using Mantel Haenzel test for trend ([Table 2](#pone.0237313.t002){ref-type="table"}).

10.1371/journal.pone.0237313.t002

###### Frequency of morbidity and mortality of the studied population based on age.
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  Age (years)   Admissions (%)   Deaths (%)   M. rate (%)   X^2^                                             Df   P-value
  ------------- ---------------- ------------ ------------- ------------------------------------------------ ---- ---------
  \<1           5,652 (11.5)     253 (11.5)   4.5           4887.235[^a^](#t002fn002){ref-type="table-fn"}   5    0.000
  1--4          5,764 (11.7)     138 (6.3)    2.4           2973.53[^b^](#t002fn003){ref-type="table-fn"}    1    0.000
  5--14         2,954 (6.0)      102 (4.6)    3.4                                                                 
  15--45        28,535 (57.9)    829 (37.7)   2.9                                                                 
  46--64        4,255 (8.6)      523 (23.8)   12.3                                                                
  ≥65           2,127 (4.3)      353 (16.1)   16.6                                                                

M.: mortality

^a^: Pearson Chi-square coefficient

^b^: Mantel Haenzel test for trend (linear by linear association)

Mortality rates for the years 2012, 2013, 2014, 2015, 2016 and 2017 were found to be 3.6%, 3.9%, 4.1%, 4.2%, 6.1% and 5.1% respectively ([Fig 2](#pone.0237313.g002){ref-type="fig"}).

![Mortality rates of the studied years (2012--2017).](pone.0237313.g002){#pone.0237313.g002}

[Table 3](#pone.0237313.t003){ref-type="table"} shows the causes of morbidity and mortality of the studied patient based on the broad ICD-10 classification. The broad ICD overall leading causes of death were infectious diseases and parasitic infections, and diseases of the circulatory system accounting for 22.7% and 15.8% of all deaths. However, diseases of the circulatory system recorded the highest number of deaths per admission (348/2,540) giving a mortality rate of 13.7%. Infectious diseases and parasitic infections were the leading causes of death in adults while conditions originating from perinatal period was the leading cause of death in children.

10.1371/journal.pone.0237313.t003

###### Distribution of causes of morbidity and mortality by broad ICD-10 classification.
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  Disease diagnostic category (ICD-10 code)                          Children (0--14 years)   Adult (≥15 years)   Total Adm.   Total death            
  ------------------------------------------------------------------ ------------------------ ------------------- ------------ ------------- -------- ------------
  Infectious and parasitic diseases                                  3,332                    106                 1,578        392           4,910    498 (22.7)
  Neoplasms                                                          86                       8                   1,303        110           1,392    118 (5.4)
  Disease of blood & blood forming organs                            549                      6                   415          61            964      67 (3.0)
  Endocrine, nutritional & metabolic diseases                        859                      24                  857          90            1,716    114 (5.2)
  Mental and behavioral disorders                                    11                       0                   82           13            93       13 (0.6)
  Diseases of the nervous system                                     276                      27                  539          106           815      133 (6.0)
  Eye and adnexa diseases                                            162                      0                   300          0             462      0 (0.0)
  Ear and mastoid process                                            97                       1                   31           0             128      1 (0.0)
  Circulatory system diseases                                        239                      27                  2,301        321           2,540    348 (15.8)
  Respiratory system diseases                                        3,382                    40                  595          78            3,977    118 (5.4)
  Diseases of the digestive system                                   325                      17                  1,839        165           2,164    182 (8.3)
  Diseases of the skin and subcutaneous tissue                       300                      9                   277          31            577      40 (1.8)
  Diseases of musculoskeletal system & connective tissue             114                      10                  282          13            396      23 (1.0)
  Diseases of the genitourinary system                               299                      17                  1,397        105           1,626    122 (5.5)
  Pregnancy, childbirth & puerperium                                 10                       1                   16,108       18            16,118   19 (0.9)
  Condition originating in the perinatal period                      2,497                    123                 1,752        2             4,249    125 (5.7)
  Congenital malformations                                           330                      33                  76           6             406      39 (1.8)
  Symptoms, signs and abnormal clinical and laboratory findings      636                      15                  639          88            1,275    103 (4.7)
  Injury and poison & other external causes                          575                      24                  1,800        83            2,375    107 (4.9)
  Factors influencing health status & contact with health services   331                      7                   2,773        21            3,104    28 (1.3)

Adm.: admission

[Table 4](#pone.0237313.t004){ref-type="table"} shows further stratification of the specific causes of death within the broad ICD 10 classification based on adult and children classification.

10.1371/journal.pone.0237313.t004

###### Distribution of causes of morbidity and mortality by broad ICD-10 classification and specific disease types.
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  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Diagnostic category (ICD-10 code)                                      Children (0--14 years)   Adult (≥15 years)   Total Adm.   Total death           
  ---------------------------------------------------------------------- ------------------------ ------------------- ------------ ------------- ------- --------------------
  **Infectious and parasitic diseases**\                                                                                                                 **n = 498 (22.7)**
  **Infectious and parasitic diseases**                                                                                                                  

   Diarrhea & gastroenteritis                                            1,154                    17                  131          14            1,285   31 (6.2)

   Septicaemia                                                           327                      38                  269          94            596     132 (26.5)

   HIV                                                                   99                       7                   324          68            423     77 (15.5)

   Other viral diseases                                                  46                       1                   244          75            290     76 (15.3)

   Malaria                                                               1,450                    23                  145          10            1,595   33 (6.6)

   Tuberculosis                                                          69                       2                   233          79            302     81 (16.3)

   Others                                                                187                      16                  232          52            419     68 (13.6)

  **Neoplasms**                                                                                                                                          **n = 118 (5.4)**

   Malignant neoplasm of lip, oral cavity                                1                        0                   19           0             20      0 (0.0)

   Malignant neoplasm of liver                                           1                        0                   58           20            59      20 (16.9)

   Malignant neoplasm of breast                                          3                        0                   141          20            144     20 (16.9)

   Malignant neoplasm of cervix & uteri                                  0                        0                   91           4             91      4 (3.4)

   Benign neoplasm of breast                                             1                        0                   19           0             20      0 (0.0)

   Leiomyoma of uteri                                                    0                        0                   350          0             350     0 (0.0)

   Others                                                                80                       8                   628          66            708     74 (62.7)

  **Disease of blood & blood forming organs**                                                                                                            **n = 67 (3.0)**

   Anemia                                                                535                      5                   379          56            914     61 (91.)

   Others                                                                14                       1                   36           5             50      6 (9.0)

  **Endocrine, nutritional & metabolic diseases**                                                                                                        **n = 114 (5.2)**

   Diabetes mellitus                                                     15                       0                   664          78            679     78 (68.4)

   Malnutrition                                                          135                      13                  9            1             144     14 (12.3)

   Volume depletion                                                      656                      6                   16           0             672     6 (5.5)

   Others                                                                53                       5                   168          11            221     16 (4.0)

  **Mental and behavioral disorders**                                                                                                                    **n = 13 (0.6)**

  **Diseases of the nervous system**                                                                                                                     **n = 133 (6.0)**

   Inflammation disease of the CNS                                       139                      19                  130          30            269     49 (36.8)

   Cerebral palsy & other paralytic syndromes                            19                       0                   203          50            222     50 (37.6%)

   Others                                                                118                      8                   206          26            324     34 (25.6)

  **Diseases of the eye and adnexa diseases**                                                                                                            **n = 0 (0.0)**

  **Diseases of the ear and mastoid process**                                                                                                            **n = 1 (0.0)**

  **Circulatory system diseases**                                                                                                                        **n = 348 (15.8)**

   Essential (primary) hypertension                                      11                       1                   274          25            285     26 (7.5)

   Other hypertensive diseases                                           6                        0                   301          28            307     28 (8.0)

   Ischaemic heart disease                                               128                      18                  547          56            675     74 (21.3)

   Stroke                                                                1                        0                   308          93            309     93 (26.7)

   Others                                                                93                       8                   871          119           964     127 (36.5)

  **Respiratory system diseases**                                                                                                                        **n = 118 (5.4)**

   Acute pharyngitis and tonsillitis                                     1018                     1                   30           0             1048    1 (0.8)

   Other acute respiratory infections                                    500                      0                   43           1             543     1 (0.8)

   Pneumonia                                                             790                      7                   110          9             900     16 (13.6)

   Acute bronchitis                                                      123                      0                   1            0             124     0 (0.0)

   Chronic disease of the tonsils & adenoids                             388                      26                  21           0             409     26 (22.0)

   Asthma                                                                372                      1                   51           0             323     1 (0.8)

   Others                                                                291                      5                   339          68            630     73 (61.9)

  **Diseases of the digestive system**                                                                                                                   **n = 182 (8.3)**

   Gastric and duodenal ulcer                                            18                       0                   201          10            219     10 (5.5)

   Diseases of the appendix                                              45                       0                   336          2             381     2 (1.1)

   Inguinal hernia                                                       63                       0                   274          11            337     11 (6.1)

   Paralytic ileus & intestinal obstruction                              65                       5                   117          8             182     13 (7.1)

   Alcohol liver disease                                                 0                        0                   11           4             11      4 (2.2)

   Other diseases of the liver                                           15                       3                   305          84            320     87 (7.8)

   Others                                                                119                      9                   595          46            714     55 (30.2)

  **Diseases of the skin & subcutaneous tissue**                                                                                                         **n = 40 (1.8)**

  **Diseases of musculoskeletal system & connective tissue**                                                                                             **n = 23 (1.0)**

  **Diseases of the genitourinary system**                                                                                                               **n = 122 (5.5)**

   Acute nephritic syndrome                                              42                       10                  241          40            283     50 (41.0)

   Real tubule interstitial                                              3                        3                   102          12            141     15 (12.3)

   Other diseases of the urinary system                                  99                       4                   349          46            448     50 (41.0)

   Others                                                                53                       0                   705          7             758     7 (5.7)

  **Pregnancy, childbirth & puerperium**                                                                                                                 **n = 19 (0.9)**

   Medical abortion                                                      0                        0                   506          5             506     5 (26.3)

   Post-partum hemorrhage                                                2                        0                   759          1             761     1 (5.3)

   Single spontaneous delivery                                           3                        0                   5,717        1             5717    1 (5.3)

   Others                                                                5                        1                   9,130        11            9,135   12 (63.1)

  **Condition originating in the perinatal period**                                                                                                      **n = 125 (5.7)**

   Fetus affected by maternal factors & Labor                            25                       0                   1,005        0             1,030   0

   Slow fetal growth, malnutrition & short gest.                         330                      21                  82           0             412     16.8

   Congenital infectious & parasitic diseases                            867                      23                  231          1             1,098   19.2

   Others                                                                1,275                    79                  434          1             1,709   64.0

  **Congenital malformations**                                                                                                                           **n = 39 (1.8)**

  **Symptoms, signs and abnormal clinical and laboratory findings**                                                                                      **n = 103 (4.7)**

  **Injury and poison & other external causes**                                                                                                          **n = 107 (4.9)**

   Fracture of limb bone                                                 40                       0                   263          4             303     4 (3.7)

   Burns and corrosion                                                   120                      18                  123          21            243     39 (36.5)

   Others                                                                415                      6                   1,414        58            1,829   64 (59.8)

  **Factors influencing health status & contact with health services**                                                                                   **n = 28 (1.3)**
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------

On individual disease assessment of the causes of death, septicaemia (6.0%), stroke (4.2%), liver diseases (4.1%), tuberculosis (3.7%), diabetes (3.6%), complications of HIV/AIDS (3.5%) and ischaemic heart disease (3.4%) were the leading causes of mortality. Further stratification based on age showed malaria, diarrhea & gastroenteritis and acute pharyngitis and tonsillitis were the leading causes of admission while sepsis, chronic diseases of the tonsil and malaria were the leading causes of mortality in children. On the other hand, single spontaneous delivery, fetus affected by maternal factors & labor, post-partum hemorrhage (obstetric reasons) and diabetes mellitus (non-obstetric reason) were the leading causes of admission, while sepsis, stroke and liver diseases were the leading causes of death in adults ([Table 5](#pone.0237313.t005){ref-type="table"}).

10.1371/journal.pone.0237313.t005

###### Summary of the leading seven specific causes of mortality in the study.
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  Specific disease                             \% of total deaths (%)   Rank     Specific disease                                                                                                                                                                                              
  -------------------------------------------- ------------------------ -------- ----------------------------------------------- ------ ----------------------------------------------- ----- -------------------------------------------- ------ -------------------------------------------- -----
  Sepsis                                       6.0                      1^st^    Malaria                                         10.0   Sepsis                                          7.7   Single spontaneous delivery                  16.4   Sepsis                                       5.5
  Stroke                                       4.2                      2^nd^    Diarrhea & gastroenteritis                      8.0    Chronic disease of the tonsils & adenoids       5.3   Fetus affected by maternal factors & Labor   2.9    Stroke                                       5.4
  Liver diseases                               4.1                      3^rd^    Acute pharyngitis and tonsillitis               7.1    Malaria                                         4.7   Post-partum hemorrhage                       2.2    Liver diseases                               4.9
  Tuberculosis                                 3.7                      4^th^    Congenital infection & parasitic diseases       6.0    Congenital infection & parasitic diseases       4.7   Diabetes                                     1.9    Tuberculosis                                 4.6
  Diabetes                                     3.6                      5^th^    Pneumonia                                       5.5    Slow fetal growth, malnutrition & short gest.   4.2   Anemia                                       1.1    Diabetes                                     4.4
  HIV                                          3.5                      6^th^    Volume depletion                                4.6    Inflammation disease of the CNS                 3.8   Leiomyoma of uteri                           1.0    Other viral diseases                         4.4
  Other viral diseases                         3.5                      7^th^    Anemia                                          3.7    Burns                                           3.6   Other diseases of the urinary system         0.9    HIV                                          4.0
  Ischemic heart disease                       3.4                      8^th^    Chronic disease of the tonsils & adenoids       2.7    Ischaemic heart disease                         3.6   Diseases of the appendix                     1.0    Ischemic heart disease                       3.3
  Acute nephritic syndrome                     2.3                      9^th^    Asthma                                          2.6    Diarrhea & gastroenteritis                      3.4   HIV                                          0.9    Anemia                                       3.3
  Cerebral palsy & other paralytic syndromes   2.3                      10^th^   Slow fetal growth, malnutrition & short gest.   2.3    Malnutrition                                    2.6   Stroke                                       0.8    Cerebral palsy & other paralytic syndromes   2.9
  Other diseases of urinary system             2.3                                                                                                                                                                                                                                             

Discussion {#sec014}
==========

In sub-Saharan Africa, population-based information are scarce, hence, hospital-based morbidity and mortality data has become relevant surrogates in assessing disease burden, quality of health care as well as policy making \[[@pone.0237313.ref016]\].

In this study, we observed mortality rate of 4.5%. This value is lower than 6.3% and 12.0% being studies in Ondo \[[@pone.0237313.ref013]\] and Kano \[[@pone.0237313.ref014]\], Nigeria. However, this observation is higher than an earlier hospital based study in Pakistan that reported mortality rate of 1.6% \[[@pone.0237313.ref024]\].

Gender stratification showed higher mortality in the male gender despite the higher admission rate of the females. This trend is similar to earlier reports from studies in Nigeria \[[@pone.0237313.ref004],[@pone.0237313.ref014],\] as well as another study in Ethiopia \[[@pone.0237313.ref025]\]. Generally, females have been shown to have lower mortality and relative longer life expectancy when compared to males \[[@pone.0237313.ref026]--[@pone.0237313.ref028]\]. This disparity has been attributed to higher mortality through injuries in males in Africa, Latin America, Caribbean and Europe \[[@pone.0237313.ref029]\]. However, a closer observation in the mode of admission offers a clue on the gender based hazard and treatment seeking behavior of the males in the studied area. Despite consisting 31.7% of the total admissions, males topped (59.8%) admission via accident and emergency/casualty ward. More males tends to be drivers and are more likely to be victims of road accident, hence, emergency admission. More so, the cultural dogma of males being "bread winners" of their families cannot be ruled out as a contributing factor to deferred health seeking behaviors. However, the addition of admissions for labour and delivery which are not actually causes of morbidities may contribute to this disparity.

Majority (37.7%) of the death recorded in this study were observed in the 15--45 years age group. This pattern is similar to earlier reports from studies in other parts of Nigeria \[[@pone.0237313.ref004],[@pone.0237313.ref016]\]. This observation is prevalent in most studies originating from Africa, mostly sub-Sahara Africa where life expectancy is short \[[@pone.0237313.ref004],[@pone.0237313.ref016]\]. Life expectancy among Nigerians has shuttered between 57.2--65.9 years and 54.1--62.8 years for females and males, respectively \[[@pone.0237313.ref030]\].

Infectious and parasitic diseases were the leading causes of mortality in this study. The finding is in consonance with previous reports in developing countries \[[@pone.0237313.ref004],[@pone.0237313.ref009],[@pone.0237313.ref016],[@pone.0237313.ref024],[@pone.0237313.ref025]\]. This is also in agreement with the report of WHO 2004 Global Burden of disease for low income countries \[[@pone.0237313.ref025]\]. On further stratification, septicaemia, tuberculosis and complications of HIV were the chief causes of death due to infectious diseases accounting for 26.5, 16.3 and 15.5% of all deaths by infectious and parasitic disease, respectively. Sepsis (a consequence of septicaemia), a syndrome of deregulated host response to infection leading to life threatening organ dysfunction, is a major global health burden \[[@pone.0237313.ref031]\] causing about 5--6 million deaths annually with majority occurring in low and middle income countries \[[@pone.0237313.ref031],[@pone.0237313.ref032]\]. Overall, septicaemia was the leading cause of both child and adult mortality and is responsible for 6.0% (132/2,198) of all deaths recorded in this study. Tuberculosis and complications of HIV accounted for 3.7 and 3.5% of the overall death becoming the 4th and 6th leading individual disease causes of death in this study. Both have been reported as the leading cause of death in sub-Saharan Africa \[[@pone.0237313.ref001],[@pone.0237313.ref033],[@pone.0237313.ref034]\]. Despite the decline trend in tuberculosis globally, multidrug resistant tuberculosis (MDR-TB) has encouraged the epidemic in low-income countries with the incidence rate not less than 20 times higher in-low income countries than their high income counterparts \[[@pone.0237313.ref035]--[@pone.0237313.ref037]\]. Human immunodeficiency virus (HIV) on the other hand, has had its highest toll of epidemic in the sub-Saharan Africa with approximately 1 in every 25 adults living with HIV \[[@pone.0237313.ref038],[@pone.0237313.ref039]\] and has been reported together with tuberculosis as leading cause of death in northwest Ethiopia \[[@pone.0237313.ref001]\]. Nigeria is now the second largest HIV disease burden in the world after South Africa which has 7.1 million (19% of global epidemic) burden of the disease, though prevalence is stable at 3.4% \[[@pone.0237313.ref038],[@pone.0237313.ref039]\]. Contrary to the result of this study, circulatory diseases were the leading cause of death in developed countries / high-income countries \[[@pone.0237313.ref007],[@pone.0237313.ref008],[@pone.0237313.ref029]\].

Diseases of the circulatory system (cardiovascular and neurovascular diseases) were the second leading broad ICD-10 cause of death in this study. This finding is similar to that reported by Nwafor and colleagues in southeastern Nigeria \[[@pone.0237313.ref004]\]. Majority of the deaths due to circulatory diseases were caused by stroke (cerebrovascular accident) (26.7%) and ischaemic heart disease (21.3%). Aside being the chief cause of death due to circulatory diseases, stroke was observed to be the overall second leading individual disease cause of death in this study accounting for 4.2% of all deaths in the study (93/2198) above liver diseases, tuberculosis, diabetes and HIV/AIDS. Similarly, Arodigwe and colleagues have reported stroke as the second leading cause of mortality in southeastern Nigeria \[[@pone.0237313.ref016]\]. In sub-Saharan Africa, circulatory diseases' incidence has reached near epidemic proportion with preponderance of stroke, hypertension, cardiomyopathies and rheumatic heart disease reported as chief causes of mortality \[[@pone.0237313.ref040]\].

Diseases of the digestive system were the 3^rd^ leading broad ICD-10 cause of death in this study. The major contributor to mortality observed in this category is liver diseases. Liver diseases represented the overall 3^rd^ leading cause of death accounting for 4.1% of all deaths recorded in the study only behind sepsis and stroke. Liver diseases has not been implicated in previous studies as top cause of mortality. However, this emerging demographic calls for concern and might not be unconnected to rise in hepatitis B and C \[[@pone.0237313.ref039]\] which play major role in pathophysiology of most liver diseases. Unlike HIV/AIDS, treatment of hepatitis B and C in Nigeria is still via "out-of-pocket" of the patient. There is no programme for free treatment of both. The observation of this study calls for urgent intervention in this regard.

One of the components of the Sustainable development goals (Millennium Development Goals) is to reduce child mortality \[[@pone.0237313.ref041]\]. Conditions originating in the perinatal period constituted 5.7% of all causes of mortality, hence, ranking the overall 5^th^ broad cause of mortality. Neonatal death is an important index used in evaluating socioeconomic development as well as an important indicator of status of a community \[[@pone.0237313.ref004],[@pone.0237313.ref042]\]. Basically, it reflects the quality of prenatal, delivery and early infant care practices prevalent in any setting \[[@pone.0237313.ref004]\].

Neoplasms (together with diseases of the respiratory system) were the 7^th^ broad leading cause of death accounting for 5.4% of the observed broad ICD-10 cause of death in this study. The specific diseases mainly involved in the mortality were malignant neoplasm of the breast and liver. This trend is consistent with previous finding in south eastern Nigeria \[[@pone.0237313.ref004]\]. However, infective agents such as hepatitis B and C are risk factors for the liver neoplasm \[[@pone.0237313.ref043]\].

Although the ICD-10 broad category of endocrine, nutritional and metabolic diseases ranked the 8^th^ cause of death, diabetes mellitus as a single disease entity ranked the 4^th^ overall cause of death in this study accounting for 3.5% of all deaths. Although Nigeria houses the highest number of persons living with diabetes in Africa \[[@pone.0237313.ref044]\], the mortality has not been recorded high in the past decades. However, a more recent (2016) WHO report documented diabetes mellitus as being responsible for 2% of all deaths in Nigeria \[[@pone.0237313.ref045]\]. The growing mortality due to diabetes as observed in this study is an indication of transition in disease burden. This is possibly due to rapidly changing demographic trends, increasing rate of urbanization and transient adoption of western life style in many African settings \[[@pone.0237313.ref046],[@pone.0237313.ref047]\].

Malaria, diarrhea & gastroenteritis, acute pharyngitis were the top causes of admission in children in this study. This finding is similar to previous studies in Nigeria that reported malaria, diarrhea/gastrointestinal diseases as the top causes of child morbidity in Bayelsa \[[@pone.0237313.ref048]\] and Delta \[[@pone.0237313.ref049]\] states, Nigeria. On the other hand, sepsis, chronic diseases of the tonsil and adenoids and malaria were the leading causes of death in children in this study. Similar to the finding of this study, Duru and colleagues have reported anemic heart failure (19.6%), sepsis (12.8%) and diarrhea (11.3%) as the leading causes of child death in Bayelsa State \[[@pone.0237313.ref048]\], while Muoneke and colleagues reported malaria (37.5%), gastroenteritis (23.6%) and broncho pneumonia (15.3%) as the leading causes of death in Ebonyi State \[[@pone.0237313.ref050]\]. Similarly, Ezeonwu *et al*., have reported malaria (24.4%), sepsis (19.9%) and respiratory infections (7.7%) as the top causes of child mortality in Delta State \[[@pone.0237313.ref049]\]. Sepsis is life threatening organ dysfunction caused by deregulated host response to infection \[[@pone.0237313.ref051]\]. Bacteria (gram positive and gram negative) are the chief culprits of sepsis \[[@pone.0237313.ref052]\]. However, fungi causes do occur \[[@pone.0237313.ref053]\]. Chronic diseases of the tonsils and adenoids are inflammatory conditions resulting from proliferation and infection of adenoids and tonsils by bacterial agents. The chief bacterial culprits are *Haemophilus influenza*, *Streptococcus pneumonia*, *Staphylococcus aureus* and more \[[@pone.0237313.ref054]\]. On the other hand, malaria is caused by protozoa of the genus plasmodium specie and transmitted by female anopheles mosquito \[[@pone.0237313.ref055],[@pone.0237313.ref056]\]. Diarrhea and gastroenteritis are mainly caused by rotavirus, norovirus, Salmonella, E. coli, campylobacter and others \[[@pone.0237313.ref057]\]. The above listed diseases are mostly preventable via simple and less cost effective measures. While sepsis and diarrhea can be ameliorated via application of simple hygiene practice, diseases of tonsils and adenoids can be reduced by childhood vaccination against some of the causative agents such as *Haemophilus influenza* and *Streptococcus spp* \[[@pone.0237313.ref048]\]. More so, malaria can be prevented by the use of insecticide treated bed nets and malaria chemoprophylaxis \[[@pone.0237313.ref048],[@pone.0237313.ref058]\].

On the part of the adults, the leading causes of hospital admissions were single spontaneous delivery, fetus affected by maternal factors and post-partum hemorrhage (which are all obstetric issues) and diabetes. Although diabetes mellitus was the top non obstetric cause of admission, it did not contribute to the top causes of mortality in adults. On the other hand, sepsis, stroke and liver diseases were the leading causes of death in adults in this study. While sepsis is uncontrolled immunological response to infection, stroke is a cerebrovascular accident that leads to loss of brain function due to disruption of blood supply to the brain \[[@pone.0237313.ref059]\]. Sepsis is a major cause of death in children and adults. There were an estimated 10 million sepsis related deaths globally in 2017 with higher inclination in low- and middle-income countries \[[@pone.0237313.ref060]\]. Improved hand hygiene practice have been documented to reduce the incidence and consequent mortality due to sepsis \[[@pone.0237313.ref061]\]. On the other hand, stroke is mainly disease of the adult. Age is a strong determinant of stroke and the risk doubles every decade above age 55 \[[@pone.0237313.ref062]\].

It is pertinent to know that malaria is the top cause of morbidity and the third cause of mortality in children, whereas same did not apply to adults. In malaria endemic regions, several acquired and adaptive immunity have been documented \[[@pone.0237313.ref063],[@pone.0237313.ref064]\]. These adaptive immunity are more developed and advanced in adults.

Amenable mortality implies deaths due to causes that otherwise shouldn't result to death in the presence of effective medical practice \[[@pone.0237313.ref002]\]. It is an indicator of national levels of personal health care access and quality \[[@pone.0237313.ref005]\]. The high level of mortality from infectious diseases and conditions originating from perinatal period reflects low access to quality health care in the studied population. This observation could be attributed to low contribution to health expenditure by Nigerian government. The Financial Global Health database capped Nigeria health expenditure at \$71 per person with 8.5% (\$6) from development for assistance for health, 14.1% (\$10) from government health spending, 76.1% (\$54) from out-of-pocket spending and 1.4% (\$1) from prepaid private spending \[[@pone.0237313.ref030]\].

Although infectious diseases constituted the majority of the causes of death observed in this study, diseases of the circulatory system recorded the highest mortality rate (13.7%) in relation to infectious diseases that had 10.1%. This is an indication for need to improve in research, practice, provision of facilities and policies in the area of circulatory / cardiovascular diseases.

Limitations {#sec015}
-----------

The result of this study is potentially prone to varying limitations. Firstly, the study took a retrospective approach, hence, inherent limitations of retrospective studies such as selective bias might not be ruled out. More so, exact causes of death were based on clinical and ancillary investigations rather than postmortem examination (autopsy). Autopsy is not a common norm in the studied area due to some cultural dogmas except in cases of conflict or jurisprudence. Also, labour and delivery may have favored higher admission in females.

Conclusion {#sec016}
==========

The data in this study showed infectious disease and circulatory system diseases as the major causes of mortality in the studied population which reflects the common mortality pattern in developing countries. Aside sepsis, stroke was the second leading cause of mortality. The study revealed double burden of both communicable and non-communicable diseases. However, Infectious and parasitic diseases, Condition originating in the perinatal period, Respiratory system diseases were the leading causes of morbidity, with malaria being the chief individual cause of morbidity. Septicaemia, chronic disease of the tonsils and adenoids and malaria were the chief causes of mortality in children, while sepsis, stroke and liver diseases were the leading causes of death in adults. We thus recommend simultaneous intervention in circulatory diseases alongside with infectious diseases.

Supporting information {#sec017}
======================
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Reviewer \#1: The study is on the causes of morbidity and mortality in a tertiary hospital in Southern Nigeria and a retrospective work.

1\. Being a retrospective work, were the authors able to verify accuracy of the diagnosis in each patient's case notes to ascertain that the diagnosis was same as coded by the records? inputting wrong diagnosis is a common error in most hospitals in developing countries

2\. The study was silent on missing data, a common problem with retrospective study.

3\. To be more meaningful, the study should reclassify age groups of patients. The study lumped older children and young adult together which is not acceptable. Internationally, pediatric age group is from birth to \<18 years; adults is 18 years to 64 years, and the elderly 65 years and above. This will allow for proper determination of leading cause of morbidity and mortality by age. Infectious diseases may not necessarily be the leading cause of morbidity and mortality among adults and elderly as concluded.

3\. The study classified stroke as cardiovascular or circulation disease; Stroke is a cerebrovascular disorder and a neurological disorder and presently the leading cause of death in Nigeria like other developing countries. it is the commonest cause of disability. please reclassify stroke appropriately.

Reviewer \#2: Given the paucity of data about in-hospital mortality and/or quality in many African countries, the paper does make a contribution to the literature. However, many points need to be clarified and/or expanded upon in order to increase the strength and interest of the article, as detailed below. The conclusions, particularly in the abstract, should also be more solidly explained as to their relation to the findings.
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-Abstract conclusion: This does not give the reader a clear understanding of the main point/findings of the paper. It is very general. The meaning of \"double burden of communicable and non-communicable diseases\" needs to be specified. Also, if the authors wish to argue that most of the deaths in the study are preventable, this needs better supporting arguments in the discussion, as below.

-Methods: is this in-hospital mortality? If not, what duration of follow-up was used?
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-Methods: who determined the cause of death which is coded by ICD-10? The treating physician?

-Results: In the last line of the first paragraph, you stated that \"mortality was significantly higher in female gender,\" however, the data suggest the opposite, and in the discussion section higher male mortality is discussed

-Results: Second paragraph, \"647.0% of the patients were admitted via casualty\"\--the number needs to be correct to 0-100%

-Results: 5th paragraph: the text would be more informative/interesting with a description of what is meant specifically by \"conditions originating from the perinatal period\"

-Results: Description of which bacterial organisms the most common cause of septicemia would very much improve the strength

-Results: The last paragraph describes the percentage of deaths due to the leading causes listed.

\(a\) What does a death due to HIV/AIDS mean? Did these patients die from the virus itself (eg, wasting syndrome, etc.) or more likely, due to opportunistic infections? Again would be helpful to outline this more specifically, and if opportunistic infections, which ones?

\(b\) It would add significant strength and interest to the paper to know: Of the patients admitted with each of these conditions, what proportion died?

-Discussion: In the discussion of higher mortality among males, it would be important to know whether the female admissions/deaths include those admitted for labor and delivery, which would be expected to make the female mortality rate appear lower\--eg, most would not be coming in \"sick.\" If this did include L+D, would consider re-analyzing without those admissions to see if the difference in male and female mortality remains.

-Discussion: The commentary on males having less \"health conscious\" behavior than females seems somewhat like conjecture and should either be removed or re-stated using less definitive language (unless able to support with literature/data)

-Discussion: A rise in Hepatitis B and C is described. Would expand upon this more given that the finding of liver disease as one of the leading causes of death was the most surprising and potentially interesting piece of new information from the study. Can you specify rates of hepatitis viruses among those with liver disease who died in your study? If not, would describe if there are limitations in availability of testing. It would also be worthwhile to discuss how patients with these viral hepatitides are managed what at your facility and/or in Nigeria in general\--are treatments available? Is this data suggesting a reason call for more specific resources for HBV and HCV?

-Discussion: the paragraph regarding conditions in the perinatal period and the Millenium Development Goals does not seem well-placed, and it is not clear how what is written here adds to the literature

-Discussion: Breast and liver cancer were described as leading causes of neoplasms, which is stated is consistent with previous findings. Previous findings from where? Similar hospital settings/LMIC\'s, etc? Should specify. Also, liver cancer as a leading neoplasm provides yet another opportunity to discuss more specifics about viral hepatitis, and connect to the above comments.

-Discussion: The argument that the mortality from infections and \"conditions originating in the perinatal period\" reflects low access to quality health care and reflects \"amenable mortality\" needs to be better supported and explained. As currently written, this reads as an assumption. Ideas include concepts such as: Preventable at what stage? If a patient presents with late-stage septic shock, just because there was an infectious cause does not necessarily mean this death could be prevented even with maximal quality of care at hospital presentation, etc.

-Discussion: I found the discussion about malaria as a cause of morbidity distracting, since the paper is focused on mortality
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Response to review comments

Reviewer \#1: The study is on the causes of morbidity and mortality in a tertiary hospital in Southern Nigeria and a retrospective work.

1\. Being a retrospective work, were the authors able to verify accuracy of the diagnosis in each patient's case notes to ascertain that the diagnosis was same as coded by the records? inputting wrong diagnosis is a common error in most hospitals in developing countries

Response:

They authors did not verify via case notes. The trained staff at health records departments do record same from case notes and submit same quarterly to Medical Advisory Committee.

2\. The study was silent on missing data, a common problem with retrospective study.

Response:

There was none in the report retrieved based on information used.

3\. To be more meaningful, the study should reclassify age groups of patients. The study lumped older children and young adult together which is not acceptable. Internationally, pediatric age group is from birth to \<18 years; adults is 18 years to 64 years, and the elderly 65 years and above. This will allow for proper determination of leading cause of morbidity and mortality by age. Infectious diseases may not necessarily be the leading cause of morbidity and mortality among adults and elderly as concluded.

Response:

There was a mistake in the labelling earlier on children. Same has been corrected children age properly listed.

3\. The study classified stroke as cardiovascular or circulation disease; Stroke is a cerebrovascular disorder and a neurological disorder and presently the leading cause of death in Nigeria like other developing countries. it is the commonest cause of disability. please reclassify stroke appropriately.

Response:

The suggestion has been done.

Reviewer \#2: Given the paucity of data about in-hospital mortality and/or quality in many African countries, the paper does make a contribution to the literature. However, many points need to be clarified and/or expanded upon in order to increase the strength and interest of the article, as detailed below. The conclusions, particularly in the abstract, should also be more solidly explained as to their relation to the findings.

In addition, there are many mistakes in grammar which need to be corrected and I would recommend an editing service to review the manuscript.

Response:

We have put more effort to rid off typological errors and mistakes.

Specific comments:

-Abstract conclusion: This does not give the reader a clear understanding of the main point/findings of the paper. It is very general. The meaning of \"double burden of communicable and non-communicable diseases\" needs to be specified. Also, if the authors wish to argue that most of the deaths in the study are preventable, this needs better supporting arguments in the discussion, as below.

Response:

We have added explanation to the earlier statement.

-Methods: is this in-hospital mortality? If not, what duration of follow-up was used?

Response:

It is an in-hospital mortality. Further details has been provided in the methods section.

-Methods: should state whether this includes Labor and Delivery (see below corollary comment re: Discussion section)

Response:

This information has been added.

-Methods: who determined the cause of death which is coded by ICD-10? The treating physician?

Response:

The attending physicians did. This information has been added to the method section.

-Results: In the last line of the first paragraph, you stated that \"mortality was significantly higher in female gender,\" however, the data suggest the opposite, and in the discussion section higher male mortality is discussed

Response:

The error has been corrected.

-Results: Second paragraph, \"647.0% of the patients were admitted via casualty\"\--the number needs to be correct to 0-100%

Response:

The error has been corrected.

-Results: 5th paragraph: the text would be more informative/interesting with a description of what is meant specifically by \"conditions originating from the perinatal period\"

Response:

This is the terminology for the ICD-10 classification of the group. Details has been done in the new part of the discussion added as the mortality discussion was done for children and adults separately.

-Results: Description of which bacterial organisms the most common cause of septicemia would very much improve the strength

Response:

This information has been added in the discussion.

-Results: The last paragraph describes the percentage of deaths due to the leading causes listed.

\(a\) What does a death due to HIV/AIDS mean? Did these patients die from the virus itself (eg, wasting syndrome, etc.) or more likely, due to opportunistic infections? Again would be helpful to outline this more specifically, and if opportunistic infections, which ones?

\(b\) It would add significant strength and interest to the paper to know: Of the patients admitted with each of these conditions, what proportion died?

Response:

We have used complications of HIV/AIDS. We do not have data on specific complications and how many died for each.

-Discussion: In the discussion of higher mortality among males, it would be important to know whether the female admissions/deaths include those admitted for labor and delivery, which would be expected to make the female mortality rate appear lower\--eg, most would not be coming in \"sick.\" If this did include L+D, would consider re-analyzing without those admissions to see if the difference in male and female mortality remains.

Response:

We have stated this in the methods and as well as in the discussion. We were not able to re stratify data deleting obstetric cases. Entered as part of the limitations.

-Discussion: The commentary on males having less \"health conscious\" behavior than females seems somewhat like conjecture and should either be removed or re-stated using less definitive language (unless able to support with literature/data)

Response:

This has been deleted.

-Discussion: A rise in Hepatitis B and C is described. Would expand upon this more given that the finding of liver disease as one of the leading causes of death was the most surprising and potentially interesting piece of new information from the study. Can you specify rates of hepatitis viruses among those with liver disease who died in your study? If not, would describe if there are limitations in availability of testing. It would also be worthwhile to discuss how patients with these viral hepatitides are managed what at your facility and/or in Nigeria in general\--are treatments available? Is this data suggesting a reason call for more specific resources for HBV and HCV?

Response:

The suggestion has been inputed. However, we do not have information on rate of hepatitis virus in the subjects with liver diseases.

-Discussion: the paragraph regarding conditions in the perinatal period and the Millenium Development Goals does not seem well-placed, and it is not clear how what is written here adds to the literature

Response:

We have placed it properly.

-Discussion: Breast and liver cancer were described as leading causes of neoplasms, which is stated is consistent with previous findings. Previous findings from where? Similar hospital settings/LMIC\'s, etc? Should specify. Also, liver cancer as a leading neoplasm provides yet another opportunity to discuss more specifics about viral hepatitis, and connect to the above comments.

Response:

The location of the finding has been inserted.

-Discussion: The argument that the mortality from infections and \"conditions originating in the perinatal period\" reflects low access to quality health care and reflects \"amenable mortality\" needs to be better supported and explained. As currently written, this reads as an assumption. Ideas include concepts such as: Preventable at what stage? If a patient presents with late-stage septic shock, just because there was an infectious cause does not necessarily mean this death could be prevented even with maximal quality of care at hospital presentation, etc.

Response:

More clarification has been done via the new part of discussion in the preventive means to avoid some of the mortalities.

-Discussion: I found the discussion about malaria as a cause of morbidity distracting, since the paper is focused on mortality

Response:

The problem has been rectified by simultaneous discussion of mortality in children and adult in the new part of the discussion introduced.

All corrections, inputs, adjustments and insertions are highlighted in red. Only deletions are not visible.
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